Highbridge Capital Management’s Aimei Health Technology Co Right AFJKR Stock Holding History

Highbridge Capital Management’s Portfolio AFJKR Stock Details AFJKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Sell	871,784 -1,260	-0.1%	-$351	0.01%	246
2026 Q1	$275K	Sell	873,044 -26,956	-3%	-$10K	0.01%	170
2025 Q4	$360K	Buy	900,000 +256,342	+40%	+$96.6K	0.01%	142
2025 Q3	$193K	Sell	643,658 -100	-0%	-$36	0.01%	144
2025 Q2	$155K	Hold	643,758	–	–	0.01%	162
2025 Q1	$232K	Sell	643,758 -900	-0.1%	-$231	0.01%	124
2024 Q4	$110K	Hold	644,658	–	–	﹤0.01%	194
2024 Q3	$148K	Hold	644,658	–	–	﹤0.01%	176
2024 Q2	$148K	Hold	644,658	–	–	﹤0.01%	161
2024 Q1	$129K	Buy	+644,658	New	+$128K	﹤0.01%	165

Other funds holding AFJKR

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Highbridge Capital Management's AFJKR Position: Q2 2026 in Review

Highbridge Capital Management reduced its Aimei Health Technology Co Right (AFJKR) stake by 0.14% in Q2 2026, selling an estimated $351 and leaving 871,784 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #246.

Highbridge Capital Management first reported a position in AFJKR in Q1 2024 and has held it in 10 quarters since. The position peaked at $360K in Q4 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q2 2026.

Highbridge Capital Management held 871,784 shares of Aimei Health Technology Co Right worth $296K as of Q2 2026.
Highbridge Capital Management sold 1,260 Aimei Health Technology Co Right shares in Q2 2026, an estimated $351.
Aimei Health Technology Co Right made up 0.01% of Highbridge Capital Management's portfolio in Q2 2026, its #246 holding.
Highbridge Capital Management first reported a position in Aimei Health Technology Co Right in Q1 2024 and has held it in 10 quarters since.
Highbridge Capital Management's Aimei Health Technology Co Right position peaked at $360K in Q4 2025.
15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q2 2026.

Based on Highbridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.